We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Alnylam Discontinues Revusiran Development

News   Oct 07, 2016

 
Alnylam Discontinues Revusiran Development
 
 
Advertisement
 

RELATED ARTICLES

Gene Therapy Beats the Blood-Brain Barrier To Cure Cat Disease

News

In a new study, successfully applied a gene therapy platform to cross the blood-brain barrier and completely correct brain defects in a cat model of a human genetic disease.

READ MORE

MicroRNA Shows Promise for Hair Regrowth

News

Researchers have identified a microRNA that plays an important role in regulating the pathway involved in follicle regeneration and could be a candidate for future hair regenerating drug development.

READ MORE

Novel Drug Delivery Method Gets Under the Skin of Psoriasis

News

A team of researchers have used an ionic liquid (IL) combination to successfully deliver a small interfering RNA (siRNA)-based treatment directly to the skin in a mouse model of psoriasis, reducing levels of inflammatory cytokines and symptoms of psoriasis, whilst avoiding systemic side effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE